Crossmark Global Holdings, Inc. Gilead Sciences, Inc. Transaction History

Crossmark Global Holdings, Inc.

  • $6.02 Billion
  • Q2 2025

A detailed history of Crossmark Global Holdings, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 513,021 shares of GILD stock, worth $60.5 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares
513,021
Previous 552,584 7.16%
Holding current value
$60.5 Million
Previous $61.9 Million 8.14%
% of portfolio
0.95%
Previous 1.13%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
SELL
$96.91 - $113.0 $3.83 Million - $4.47 Million
-39,563 Reduced 7.16%
513,021 $56.9 Million
Q1 2025

Apr 29, 2025
BUY
$89.14 - $117.41 $1.1 Million - $1.45 Million
12,364 Added 2.29%
552,584 $61.9 Million
Q4 2024

Jan 16, 2025
BUY
$83.95 - $97.9 $733,806 - $855,743
8,741 Added 1.64%
540,220 $49.9 Million
Q3 2024

Nov 04, 2024
BUY
$66.59 - $83.99 $2.29 Million - $2.89 Million
34,381 Added 6.92%
531,479 $44.6 Million
Q2 2024

Jul 29, 2024
BUY
$63.15 - $72.88 $736,139 - $849,562
11,657 Added 2.4%
497,098 $34.1 Million
Q1 2024

May 13, 2024
SELL
$71.58 - $87.29 $1.91 Million - $2.33 Million
-26,656 Reduced 5.21%
485,441 $35.6 Million
Q4 2023

Feb 13, 2024
SELL
$73.27 - $83.09 $252,122 - $285,912
-3,441 Reduced 0.67%
512,097 $41.5 Million
Q3 2023

Nov 08, 2023
BUY
$73.94 - $80.67 $234,833 - $256,207
3,176 Added 0.62%
515,538 $39.2 Million
Q2 2023

Jul 31, 2023
BUY
$76.01 - $86.7 $3.3 Million - $3.76 Million
43,381 Added 9.25%
512,362 $39.4 Million
Q1 2023

May 12, 2023
BUY
$77.31 - $88.08 $9.35 Million - $10.6 Million
120,885 Added 34.73%
468,981 $38.9 Million
Q4 2022

Jan 19, 2023
BUY
$62.32 - $89.47 $963,591 - $1.38 Million
15,462 Added 4.65%
348,096 $29.9 Million
Q3 2022

Nov 01, 2022
BUY
$59.54 - $68.01 $228,871 - $261,430
3,844 Added 1.17%
332,634 $20.5 Million
Q2 2022

Jul 29, 2022
BUY
$57.72 - $65.01 $391,745 - $441,222
6,787 Added 2.11%
328,790 $20.3 Million
Q1 2022

May 11, 2022
BUY
$57.92 - $72.58 $5.32 Million - $6.67 Million
91,879 Added 39.93%
322,003 $19.1 Million
Q4 2021

Jan 10, 2022
BUY
$64.88 - $73.64 $2.23 Million - $2.53 Million
34,412 Added 17.58%
230,124 $16.7 Million
Q3 2021

Oct 21, 2021
BUY
$67.69 - $73.03 $10.3 Million - $11.1 Million
151,654 Added 344.21%
195,712 $13.7 Million
Q3 2021

Oct 13, 2021
SELL
$67.69 - $73.03 $10.3 Million - $11.1 Million
-151,608 Reduced 77.48%
44,058 $1.46 Million
Q2 2021

Jul 21, 2021
BUY
$63.47 - $69.35 $614,199 - $671,099
9,677 Added 5.2%
195,666 $13.5 Million
Q1 2021

Apr 15, 2021
BUY
$60.0 - $68.46 $10,620 - $12,117
177 Added 0.1%
185,989 $12 Million
Q4 2020

Jan 14, 2021
SELL
$56.65 - $64.55 $275,092 - $313,454
-4,856 Reduced 2.55%
185,812 $10.8 Million
Q3 2020

Oct 08, 2020
SELL
$62.1 - $78.08 $477,859 - $600,825
-7,695 Reduced 3.88%
190,668 $12 Million
Q2 2020

Aug 14, 2020
SELL
$72.34 - $84.0 $936,007 - $1.09 Million
-12,939 Reduced 6.12%
198,363 $15.3 Million
Q1 2020

Apr 28, 2020
SELL
$62.63 - $80.22 $251,208 - $321,762
-4,011 Reduced 1.86%
211,302 $15.8 Million
Q4 2019

Feb 06, 2020
BUY
$61.62 - $67.78 $281,233 - $309,347
4,564 Added 2.17%
215,313 $14 Million
Q3 2019

Oct 09, 2019
SELL
$62.51 - $69.0 $351,556 - $388,056
-5,624 Reduced 2.6%
210,749 $13.4 Million
Q2 2019

Jul 09, 2019
SELL
$61.87 - $69.38 $136,732 - $153,329
-2,210 Reduced 1.01%
216,373 $14.6 Million
Q1 2019

May 02, 2019
BUY
$62.53 - $70.05 $386,060 - $432,488
6,174 Added 2.91%
218,583 $14.2 Million
Q4 2018

Jan 31, 2019
BUY
$60.54 - $79.0 $534,749 - $697,807
8,833 Added 4.34%
212,409 $13.3 Million
Q3 2018

Nov 08, 2018
BUY
$71.28 - $78.92 $36,994 - $40,959
519 Added 0.26%
203,576 $15.7 Million
Q2 2018

Jul 31, 2018
SELL
$64.88 - $75.68 $35,684 - $41,624
-550 Reduced 0.27%
203,057 $14.4 Million
Q1 2018

Apr 16, 2018
SELL
$72.84 - $88.8 $1.62 Million - $1.97 Million
-22,187 Reduced 9.83%
203,607 $15.4 Million
Q4 2017

Feb 05, 2018
BUY
$71.15 - $83.52 $287,303 - $337,253
4,038 Added 1.82%
225,794 $16.2 Million
Q3 2016

Oct 25, 2017
BUY
N/A
221,756
221,756 $18 Million

Others Institutions Holding GILD

# of Institutions
2,328
Shares Held
1.02B
Call Options Held
12.1M
Put Options Held
9.13M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $148B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email